Prevalence and features of chronic viral hepatitis and HIV coinfection in Italian prisons

      The health of prisoners has complex needs, being the result of a combination of several factors. People who access the prison are at greater risk of contracting serious infections such as Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), and Human Immunodeficiency Virus (HIV).


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • World Health Organization
        Hepatitis: frequently asked questions.
        Date: 2014
        (Available from:)
        • Stasi C.
        • Silvestri C.
        • Voller F.
        • Cipriani F.
        The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine.
        J Infect Public Health. 2015 Jul 3; ([pii: S1876–0341(15)00101-X, Epub ahead of print])
        • Lacombe K.
        • Rockstroh J.
        HIV and viral hepatitis coinfections: advances and challenges.
        Gut. 2012; 61: i47-i58
        • Alter M.J.
        Epidemiology of viral hepatitis and HIV co-infection.
        J Hepatol. 2006; 44: S6-S9
        • Chen J.Y.
        • Feeney E.R.
        • Chung R.T.
        HCV and HIV co-infection: mechanisms and management.
        Nat Rev Gastroenterol Hepatol. 2014; 11: 362-371
        • Voller F.
        • Silvestri C.
        • Orsini C.
        • Aversa L.
        • Da Frè M.
        • Cipriani F.
        The health conditions of prison inmates in Tuscany.
        Epidemiol Prev. 2011; 35: 297-306
        • Stasi C.
        • Zignego A.L.
        • Laffi G.
        • Rosselli M.
        The liver–cytokine–brain circuit in interferon-based treatment of patients with chronic viral hepatitis.
        J Viral Hepat. 2011; 18: 525-532
        • Stasi C.
        • Rosselli M.
        • Zignego A.L.
        • Laffi G.
        • Milani S.
        Serotonin and its implication in the side effects of interferon based-treatment of patients with chronic viral hepatitis: pharmacological interventions.
        Hepatol Res. 2014; 44: 9-16
        • Stasi C.
        • Silvestri C.
        • Bravi S.
        • Aquilini D.
        • Casprini P.
        • Epifani C.
        • et al.
        Hepatitis B and C epidemiology in an urban cohort in Tuscany (Italy).
        Clin Res Hepatol Gastroenterol. 2015; 39: e13-e15
        • Puglia M.
        • Stasi C.
        • Da Frè M.
        • Voller F.
        Prevalence and characteristics of HIV/HBV and HIV/HCV coinfections in Tuscany.
        Braz J Infect Dis. 2015 Dec 31; ([pii: S1413-8670(15)00220-2])